8 results
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
HIV-AIDS Preventing Clinical ... Disease Note: Treatment ... and preventing clinical ... #management #opportunistic ... #infections #HIVAIDS
Chagas Disease (American trypanosomiasis) - Diagnosis and Management Summary
Acute Chagas Disease (8-12 weeks):
 • Mild: Malaise,
Diagnosis and Management ... Disease (8-12 weeks ... • Treatment: ... useful for chronic infection ... T.cruzi without clinical
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
noncompliance • Clinical ... initiation Clinical ... • Parvovirus B19 ... infection Treatment ... Differential #Diagnosis #Management
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Seizures • Vision changes ... territories signal changes ... Diagnosis: • Infection ... epilepticus Treatment ... Syndrome #diagnosis #management
Chagas Disease (American trypanosomiasis) - Diagnosis and Management Summary
Acute Chagas Disease (8-12 weeks):
 • Mild: Malaise,
Diagnosis and Management ... Disease (8-12 weeks ... • Treatment: ... useful for chronic infection ... T.cruzi without clinical
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis Infection ... a person with infectious ... 50 mg weekly x 12 ... HIV-infected persons with clinical ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Histoplasma Capsulatum Infections ... weeks or until clinically ... BID for at least 12 ... IDSA #Prevention #Treatment ... #management #opportunistic
Thiopurines in IBD
Indications:
 • Steroid-sparing agents indicated for maintenance of remission in UC and CD
 •
and after dose changes ... associated to good clinical ... Safety: • Serious Infections ... #BowelDisease #Management ... #Treatment